Newsroom

CAMBRIDGE, Mass. & MALVERN, Pa.--(BUSINESS WIRE)--Galera Therapeutics, Inc. (“Galera”) (OTC: GRTX), a clinical-stage biopharmaceutical company focused on advancing a pan-NOS inhibitor through clinical development for patients with the hardest-to-treat forms of advanced breast cancer, and Obsidian Therapeutics, Inc. (“Obsidian”), a privately-held clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor infiltrating lymphocyte, (“TIL”), c...

NEW YORK--(BUSINESS WIRE)--Triple Helix Institute for Agriculture, Climate, and Society (Triple Helix), a nonprofit dedicated to building cross-sector engagement and public understanding around agriculture technology (AgTech), today announced Dr. Nick Dokoozlian as the recipient of its inaugural Triple Helix AgTech Leadership Prize. Extreme weather, soil degradation, pests and diseases, and resource scarcity increasingly jeopardize crops. Emerging technologies offer pathways to improve agricult...

CHARLOTTE, N.C.--(BUSINESS WIRE)--PCI Pal® (LON: PCIP), the global provider of secure payment solutions, has further strengthened its position as a trusted enterprise partner with the achievement of SOC 2 Type II attestation, delivering a level of assurance that goes beyond industry norms. While many vendors rely on SOC 2 alone, PCI Pal has taken a more comprehensive approach. By combining SOC 2 Type II with HITRUST certification, the organization is setting a higher standard for security and c...

SAN FRANCISCO--(BUSINESS WIRE)--PAX, a leading global cannabis brand rooted in science and innovation, today released new research demonstrating that vaporizing cannabis flower can dramatically reduce exposure to harmful combustion byproducts compared to smoking a joint. The study compared chemical emissions from combusted cannabis flower in a traditional joint to aerosol produced by the PAX FLOW and PAX TRIP vaporizers under standardized puffing conditions1. Researchers analyzed sixteen harmfu...

MINNEAPOLIS--(BUSINESS WIRE)--Tennant Company (NYSE: TNC) today announced a significant evolution in its long-standing relationship with Brain Corp, signing a 3-year exclusivity extension for next-generation robotic floor care, accelerating new product development with plans to release 10 new products within 24 months, and simplifying the customer buying experience. Together, these actions support the growth of Tennant’s strategic focus on robotic cleaning and reinforce the Company’s commitment...

CAMDEN, N.J.--(BUSINESS WIRE)--The Campbell’s Company (NASDAQ:CPB) and The Campbell’s Foundation today announced $1 million in Community Impact Grants—the grant program’s largest single-year annual investment—awarded to 50 nonprofit organizations working to improve lives in communities where Campbell’s operates. The grants support the Foundation’s three strategic focus areas: increasing food access, encouraging healthy living and strengthening neighborhoods. This year, grants will support organ...

RAVENSBURG, Germany--(BUSINESS WIRE)--Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), announced significant progress in the continued expansion of its global clinical manufacturing network. With the ongoing scale-up of its Vetter Development Service offering, the company is taking important steps to provide necessary capacity, advanced technologies, and specialized expertise in response to rising demand for in-human trial material. By further strengthening i...

SEATTLE--(BUSINESS WIRE)--CDB Aviation delivered a second Boeing 737-8 to South Korea’s T’way Air....

ROSWELL, Ga.--(BUSINESS WIRE)--Eirion Risk Underwriters today announced the launch of its Construction Professional Liability (CPL) program, a specialized insurance solution designed to address the professional liability exposures faced by contractors and construction project stakeholders. The program offers a suite of coverages including Annual Contractors Professional and Pollution Liability (CPPL), Project-Specific CPPL, and Owner’s Protective Professional Indemnity (OPPI). Supported by A+ X...

DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (Nasdaq: LTRN) (“Lantern” or the “Company”), an AI-driven clinical-stage precision oncology company, today announced that withZeta.ai — the world’s first and most comprehensive multi-agentic AI co-scientist for rare cancer drug discovery, development, biomedical research, molecular design and clinical trial development — is now commercially live and actively onboarding subscribers. Subscriptions are available immediately at withzeta.ai, spanning intr...